The number of people affected by type-2 diabetes worldwide is staggering, and its incidence is increasing. The need for early detection solutions is clear. Read more...
Our multinational consortium includes institutes and enterprises at the forefront of optoacoustic technologies, metabolomics, proteomics and genomics analytics. Read more...
The OPTOMICS project aims to develop a digital twin model for non-invasive and cost-effective early detection, prevention and treatment of type-2 diabetes.Read more...
A digital twin is a virtual representation of a real-world physical object or process. The OPTOMICS project aims to develop a digital twin by integrating deep molecular characterization of changes in metabolite and protein levels with genome-wide sequencing. The result will be a digital reference tool for understanding type-2 diabetes and developing precise early predictors of the disease.
Read more…
Join our mailing list
